189
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Clinical Value and Potential Mechanisms of LINC00221 in Hepatocellular Carcinoma Based on Integrated Analysis

, , , , , & ORCID Icon show all
Pages 299-317 | Received 23 Sep 2020, Accepted 17 Dec 2020, Published online: 07 Jan 2021

References

  • Ferlay J , ColombetM , SoerjomataramIet al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer144(8), 1941–1953 (2019).
  • Singal AG , LamperticoP , NahonP. Epidemiology and surveillance for hepatocellular carcinoma: new trends. J. Hepatol.72(2), 250–261 (2020).
  • Zhou J , SunH-C , WangZet al. Guidelines for diagnosis and treatment of primary liver cancer in China (2017 edition). Liver Cancer7(3), 235–260 (2018).
  • Zheng R , QuC , ZhangSet al. Liver cancer incidence and mortality in China: temporal trends and projections to 2030. Chin. J. Cancer Res.30(6), 571–579 (2018).
  • Luo P , WuS , YuYet al. Current status and perspective biomarkers in AFP negative HCC: towards screening for and diagnosing hepatocellular carcinoma at an earlier stage. Pathol. Oncol. Res.26(2), 599–603 (2020).
  • Yang JD , HainautP , GoresGJ , AmadouA , PlymothA , RobertsLR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol.16(10), 589–604 (2019).
  • Gerstein MB , KundajeA , HariharanMet al. Architecture of the human regulatory network derived from ENCODE data. Nature489(7414), 91–100 (2012).
  • Djebali S , DavisCA , MerkelAet al. Landscape of transcription in human cells. Nature489(7414), 101–108 (2012).
  • Schmitt AM , ChangHY. Long noncoding RNAs in cancer pathways. Cancer Cell29(4), 452–463 (2016).
  • Zeng Y-L , GuoZ-Y , SuH-Z , ZhongF-D , JiangK-Q , YuanG-D. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. World J. Gastroenterol.25(48), 6902–6915 (2019).
  • Sahu A , SinghalU , ChinnaiyanAM. Long noncoding RNAs in cancer: from function to translation. Trends Cancer1(2), 93–109 (2015).
  • Anastasiadou E , JacobLS , SlackFJ. Non-coding RNA networks in cancer. Nat. Rev. Cancer18(1), 5–18 (2018).
  • Yan S , TangZ , ChenKet al. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression. J. Exp. Clin. Cancer Res.37(1), 214 (2018).
  • Kallen AN , ZhouX-B , XuJet al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol. Cell52(1), 101–112 (2013).
  • Wang Y , SunL , WangLet al. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis.9(9), 851 (2018).
  • Li Y , GuoD , LuGet al. LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma. Cell Death Dis.11(8), 685 (2020).
  • Villa E , CritelliR , LeiBet al. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. Gut65(5), 861–869 (2016).
  • Zubiete-Franco I , García-RodríguezJL , Lopitz-OtsoaFet al. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer. EBioMedicine40, 406–421 (2019).
  • Cao Z , PanX , YangY , HuangY , ShenH-B. The lncLocator: a subcellular localization predictor for long non-coding RNAs based on a stacked ensemble classifier. Bioinformatics34(13), 2185–2194 (2018).
  • Uhlen M , ZhangC , LeeSet al. A pathology atlas of the human cancer transcriptome. Science357(6352), eaan2507 (2017).
  • Rudnick PA , MarkeySP , RothJet al. A description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) common data analysis pipeline. J. Proteome Res.15(3), 1023–1032 (2016).
  • Zhang L , GongY , WangS , GaoF. Anti-colorectal cancer mechanisms of formononetin identified by network pharmacological approach. Med. Sci. Monit.25, 7709–7714 (2019).
  • Uo T , VeenstraTD , MorrisonRS. Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J. Neurosci.29(9), 2824–2832 (2009).
  • Al Haddad M , El-RifR , HannaSet al. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation. Cell Commun. Signal.18(1), 144 (2020).
  • Baek SY , HwangUW , SukHY , KimYW. Hemistepsin A inhibits cell proliferation and induces G0/G1-phase arrest, cellular senescence and apoptosis via the AMPK and p53/p21 signals in human hepatocellular carcinoma. Biomolecules10(5), 713 (2020).
  • Tang H , HanX , LiM , LiT , HaoY. Linc00221 modulates cisplatin resistance in non-small-cell lung cancer via sponging miR-519a. Biochimie162, 134–143 (2019).
  • Huang M , ZhengJ , RenY , ZhuJ , KouL , NieJ. LINC00221 suppresses the malignancy of children acute lymphoblastic leukemia. Biosci. Rep.40(5), BSR20194070 (2020).
  • Joshi BH , LelandP , LababidiS , VarrichioF , PuriRK. Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease. Cancer Med.3(6), 1615–1628 (2014).
  • Heimbach JK , KulikLM , FinnRSet al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology67(1), 358–380 (2018).
  • Tzartzeva K , ObiJ , RichNEet al. Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis. Gastroenterology154(6), 1706–1718.e1 (2018).
  • Li R , YangD , TangC-Let al. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography. BMC Cancer16, 158 (2016).
  • Yao M , YaoD-F , BianY-Zet al. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int.12(2), 171–179 (2013).
  • Luo P , LiangC , ZhangXet al. Identification of long non-coding RNA ZFAS1 as a novel biomarker for diagnosis of HCC. Biosci. Rep.38(4), BSR20171359 (2018).
  • Long J , BaiY , YangXet al. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma. Cancer Cell Int.19, 90 (2019).
  • Borgi M , CollacchiB , OrtonaE , CirulliF. Stress and coping in women with breast cancer: unravelling the mechanisms to improve resilience. Neurosci. Biobehav. Rev.119, 406–421 (2020).
  • Rashid F , ShahA , ShanG. Long non-coding RNAs in the cytoplasm. Genomics Proteomics Bioinformatics14(2), 73–80 (2016).
  • Fornari F , MilazzoM , ChiecoPet al. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J. Pathol.227(3), 275–285 (2012).
  • Shi X , LiuT-T , YuX-Net al. MicroRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Oncogene39(35), 5768–5781 (2020).
  • Yu Y , ZhaoD , LiKet al. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway. Cell Death Dis.11(4), 273 (2020).
  • Huang J , YangJ , LeiYet al. An ANCCA/PRO2000-miR-520a-E2F2 regulatory loop as a driving force for the development of hepatocellular carcinoma. Oncogenesis5(5), e229 (2016).
  • Lei Z , TangX , SiAet al. MicroRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6. Exp. Cell Res.390(1), 111955 (2020).
  • Xue J , LiuY , LuoFet al. Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis. Biochim. Biophys. Acta Mol. Basis Dis.1863(3), 753–763 (2017).
  • Xiao G , JinL-L , LiuC-Qet al. EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma. J. Immunother. Cancer7(1), 300 (2019).
  • Pu J , WangJ , WeiHet al. LncRNA MAGI2-AS3 prevents the development of HCC via recruiting KDM1A and promoting H3K4me2 demethylation of the RACGAP1 promoter. Mol. Ther. Nucleic Acids18, 351–362 (2019).
  • Glinskii AB , MaS , MaJet al. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders. Cell Cycle10(20), 3571–3597 (2011).
  • Pu M , ChenJ , TaoZet al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell. Mol. Life Sci.76(3), 441–451 (2019).
  • Zhou J-M , LiangR , ZhuS-Yet al. LncRNA WWC2-AS1 functions as a novel competing endogenous RNA in the regulation of FGF2 expression by sponging miR-16 in radiation-induced intestinal fibrosis. BMC Cancer19(1), 647 (2019).
  • Seguin L , LiotC , MzaliRet al. CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase. Mol. Cell. Biol.29(2), 570–581 (2009).
  • Wang SM , OoiLLPJ , HuiKM. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma. Clin. Cancer Res.17(18), 6040–6051 (2011).
  • Au SL-K , WongCC-L , LeeJM-F , WongC-M , NgIO-L. EZH2-mediated H3K27me3 is involved in epigenetic repression of deleted in liver cancer 1 in human cancers. PLoS One8(6), e68226 (2013).
  • Swartz KL , WoodSN , MurthyTet al. E2F-2 promotes nuclear condensation and enucleation of terminally differentiated erythroblasts. Mol. Cell. Biol.37(1), e00274-16 (2017).
  • Prieto-Dominguez N , ParnellC , TengY. Drugging the small GTPase pathways in cancer treatment: promises and challenges. Cells8(3), 255 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.